📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The future of EPAC-targeted therapies: agonism versus antagonism. (2015)

First Author: Parnell E

Attributed to: The Cyclic AMP-GEF/C/EBP Pathway; a New PKA-independent Route for the Control of Gene Expression by Cyclic AMP funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.tips.2015.02.003

PubMed Identifier: 25744542

Publication URI: http://europepmc.org/abstract/MED/25744542

Type: Journal Article/Review

Volume: 36

Parent Publication: Trends in pharmacological sciences

Issue: 4

ISSN: 0165-6147